Durham, NC, United States of America

Kestutis P Biciunas

USPTO Granted Patents = 6 


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Durnam, NC (US) (2013)
  • Durham, NC (US) (2010 - 2016)

Company Filing History:


Years Active: 2010-2016

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kestutis P Biciunas: Innovator in Pharmaceutical Compounds

Introduction

Kestutis P Biciunas is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating sexual dysfunctions. With a total of 6 patents to his name, Biciunas has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents are innovative compositions and methods for the treatment of sexual dysfunctions. One of his notable inventions involves delta opioid receptor agonist compounds. This pharmaceutical composition is designed to be administered to a subject in an amount effective to delay the onset of ejaculation during sexual stimulation. This groundbreaking work highlights his commitment to addressing important health issues.

Career Highlights

Throughout his career, Kestutis P Biciunas has worked with various companies, including Versi Group, LLC and Mount Cook Bio Sciences, Inc. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical sciences.

Collaborations

Biciunas has collaborated with esteemed colleagues such as Kwen-Jen Chang and William Pendergast. These partnerships have further enriched his research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Kestutis P Biciunas is a distinguished inventor whose work in pharmaceutical compounds has the potential to significantly impact the treatment of sexual dysfunctions. His dedication to innovation and collaboration continues to drive advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…